World Briefs
AP Wire Published:
TORONTO Canadian regulators ordered a drug for attention deficit hyperactivity disorder off the market because of reports that it has been linked to 20 sudden deaths and a dozen strokes, including some among children.
The U.S. Food and Drug Administrati
sign out Welcome,
(edit)